HIGHLIGHTS
- who: Félicien Le Louedec et al. from the Institut Claudius-Regaud, Institut Universitaire du de Toulouse (IUCT)-Oncopole, and Research Center of Toulouse (CRCT), University of Toulouse have published the paper: Cancer Immunotherapy Dosing: A Pharmacokinetic/Pharmacodynamic Perspective, in the Journal: (JOURNAL)
- what: To better understand whether or not could be an actionable item in oncology in this review preclinical and clinical development of immune checkpoint inhibitors are described particularly from the angle of dose finding studies.
- future: But further analysis considering the average weight of cancer patients (75 kg) showed that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.